465 related articles for article (PubMed ID: 32992835)
21. Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation.
Buchwald ZS; Wynne J; Nasti TH; Zhu S; Mourad WF; Yan W; Gupta S; Khleif SN; Khan MK
Front Oncol; 2018; 8():612. PubMed ID: 30619752
[TBL] [Abstract][Full Text] [Related]
22. Combining Radiation Therapy with Immune Checkpoint Blockade for Central Nervous System Malignancies.
D'Souza NM; Fang P; Logan J; Yang J; Jiang W; Li J
Front Oncol; 2016; 6():212. PubMed ID: 27774435
[TBL] [Abstract][Full Text] [Related]
23. Combination of radiotherapy and vaccination overcomes checkpoint blockade resistance.
Zheng W; Skowron KB; Namm JP; Burnette B; Fernandez C; Arina A; Liang H; Spiotto MT; Posner MC; Fu YX; Weichselbaum RR
Oncotarget; 2016 Jul; 7(28):43039-43051. PubMed ID: 27343548
[TBL] [Abstract][Full Text] [Related]
24. Radiation dose and schedule influence the abscopal effect in a bilateral murine CT26 tumor model.
Ghaffari-Nazari H; Alimohammadi M; Alimohammadi R; Rostami E; Bakhshandeh M; Webster TJ; Mahmoodi Chalbatani G; Tavakkol-Afshari J; Amir Jalali S
Int Immunopharmacol; 2022 Jul; 108():108737. PubMed ID: 35417831
[TBL] [Abstract][Full Text] [Related]
25. Radiotherapy Both Promotes and Inhibits Myeloid-Derived Suppressor Cell Function: Novel Strategies for Preventing the Tumor-Protective Effects of Radiotherapy.
Ostrand-Rosenberg S; Horn LA; Ciavattone NG
Front Oncol; 2019; 9():215. PubMed ID: 31001479
[TBL] [Abstract][Full Text] [Related]
26. The Abscopal Effect in the Era of Cancer Immunotherapy: a Spontaneous Synergism Boosting Anti-tumor Immunity?
Hlavata Z; Solinas C; De Silva P; Porcu M; Saba L; Willard-Gallo K; Scartozzi M
Target Oncol; 2018 Apr; 13(2):113-123. PubMed ID: 29470785
[TBL] [Abstract][Full Text] [Related]
27. Abscopal Effects of Local Radiotherapy Are Dependent on Tumor Immunogenicity.
Lai JZ; Zhu YY; Liu Y; Zhou LL; Hu L; Chen L; Zhang QY
Front Oncol; 2021; 11():690188. PubMed ID: 34249740
[TBL] [Abstract][Full Text] [Related]
28. Abscopal Effects With Hypofractionated Schedules Extending Into the Effector Phase of the Tumor-Specific T-Cell Response.
Zhang X; Niedermann G
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):63-73. PubMed ID: 29534901
[TBL] [Abstract][Full Text] [Related]
29. Radiotherapy combined with immunotherapy could improve the immune infiltration of melanoma in mice and enhance the abscopal effect.
Zheng Y; Liu X; Li N; Zhao A; Sun Z; Wang M; Luo J
Radiat Oncol J; 2023 Jun; 41(2):129-139. PubMed ID: 37403355
[TBL] [Abstract][Full Text] [Related]
30. PD-1 Restrains Radiotherapy-Induced Abscopal Effect.
Park SS; Dong H; Liu X; Harrington SM; Krco CJ; Grams MP; Mansfield AS; Furutani KM; Olivier KR; Kwon ED
Cancer Immunol Res; 2015 Jun; 3(6):610-9. PubMed ID: 25701325
[TBL] [Abstract][Full Text] [Related]
31. Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination.
Grapin M; Richard C; Limagne E; Boidot R; Morgand V; Bertaut A; Derangere V; Laurent PA; Thibaudin M; Fumet JD; Crehange G; Ghiringhelli F; Mirjolet C
J Immunother Cancer; 2019 Jun; 7(1):160. PubMed ID: 31238970
[TBL] [Abstract][Full Text] [Related]
32. Reeducating Tumor-Associated Macrophages Using CpG@Au Nanocomposites to Modulate Immunosuppressive Microenvironment for Improved Radio-Immunotherapy.
Cao Y; Ding S; Zeng L; Miao J; Wang K; Chen G; Li C; Zhou J; Bian XW; Tian G
ACS Appl Mater Interfaces; 2021 Nov; 13(45):53504-53518. PubMed ID: 34704726
[TBL] [Abstract][Full Text] [Related]
33. Combining radiotherapy and ipilimumab induces clinically relevant radiation-induced abscopal effects in metastatic melanoma patients: A systematic review.
Chicas-Sett R; Morales-Orue I; Rodriguez-Abreu D; Lara-Jimenez P
Clin Transl Radiat Oncol; 2018 Feb; 9():5-11. PubMed ID: 29594244
[TBL] [Abstract][Full Text] [Related]
34. Tumor Size Matters-Understanding Concomitant Tumor Immunity in the Context of Hypofractionated Radiotherapy with Immunotherapy.
Nesseler JP; Lee MH; Nguyen C; Kalbasi A; Sayre JW; Romero T; Nickers P; McBride WH; Schaue D
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32197352
[TBL] [Abstract][Full Text] [Related]
35. Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity.
Donlon NE; Power R; Hayes C; Reynolds JV; Lysaght J
Cancer Lett; 2021 Apr; 502():84-96. PubMed ID: 33450360
[TBL] [Abstract][Full Text] [Related]
36. Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors.
Eckert F; Zwirner K; Boeke S; Thorwarth D; Zips D; Huber SM
Front Immunol; 2019; 10():407. PubMed ID: 30930892
[TBL] [Abstract][Full Text] [Related]
37. Abscopal effects of radiotherapy and combined mRNA-based immunotherapy in a syngeneic, OVA-expressing thymoma mouse model.
Basler L; Kowalczyk A; Heidenreich R; Fotin-Mleczek M; Tsitsekidis S; Zips D; Eckert F; Huber SM
Cancer Immunol Immunother; 2018 Apr; 67(4):653-662. PubMed ID: 29335856
[TBL] [Abstract][Full Text] [Related]
38. Reduction of Lung Metastases in a Mouse Osteosarcoma Model Treated With Carbon Ions and Immune Checkpoint Inhibitors.
Helm A; Tinganelli W; Simoniello P; Kurosawa F; Fournier C; Shimokawa T; Durante M
Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):594-602. PubMed ID: 32980497
[TBL] [Abstract][Full Text] [Related]
39. Radiation therapy and immunotherapy-a potential combination in cancer treatment.
Asna N; Livoff A; Batash R; Debbi R; Schaffer P; Rivkind T; Schaffer M
Curr Oncol; 2018 Oct; 25(5):e454-e460. PubMed ID: 30464697
[TBL] [Abstract][Full Text] [Related]
40. Combinatorial strategies of radiotherapy and immunotherapy in nasopharyngeal carcinoma.
Yeo ELL; Li YQ; Soo KC; Wee JTS; Chua MLK
Chin Clin Oncol; 2018 Apr; 7(2):15. PubMed ID: 29764160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
